this must be archive.php

Let’s Talk About Blood Cancer

MDS Patient Support
MDS Patient Support

September is Blood Cancer Awareness Month: Get involved!

More than a million people are diagnosed with blood cancer around the world every year – yet there is still relatively low awareness of it.

Get involved in the MDS Alliance’s #LetsTalkAboutBloodCancer campaign, and help support the fight against blood cancer.

MDS Patient Support
MDS Patient Support

Share these images on social media!

  • To raise general awareness of blood cancers and MDS specifically
  • To encourage people to become blood and stem cell donors
  • To educate people on clinical trials and modern blood matching technology

Save these images onto your mobile phone and share them as widely as you can on Twitter, Facebook, Instagram or Whatsapp.

MDS Patient Support
MDS Patient Support
MDS Patient Support
MDS Patient Support

What is the impact of MDS on your family?

A person’s health condition has a huge impact on the quality of life of the person, but also on their partner and family members. This impact has been largely ignored.

Researchers at Cardiff University have created a questionnaire, the Family Reported Outcome Measure (FROM-16), to assess this impact.

This questionnaire needs further testing and this can only be achieved with the help of people such as yourself.

The researchers hope this information will:

  • encourage improved patient and family care
  • help clinicians choose treatments that are better for the needs of the patient and family members.

Please help them by completing this short questionnaire. All answers will be kept anonymous and it only takes 5-minutes to complete!

 

The survey has two sections:

  • The first part is to be completed by the person living with a health condition.
  • The second part is to be completed by that person’s partner or family member.

It is important that both sections are completed.  Only people aged 18 years or over can take part in this study.

A big thank you from the research team at Cardiff University.


An amazing team run the Great North Run for MDS UK!

We had an amazing team running for MDS UK Patient Support Group!

MDS Patient Support

You can still help our runners achieve their fundraising targets!

MDS Patient Support

Declan Brady

MDS Patient Support

Laura and Matt

MDS Patient Support

Harriet Kirby

MDS Patient Support

Emma Paine

We would like to give a BIG THANKS to our dear friend Nick Hall - who rode the Prudential ride for us in 2019. Nick spoke to his gym friends at Easy St. and ten of them have signed up to run for MDS UK!  Lucie Berwick and Jamie Ford, trainers at the gym, are also running for us. What a generous bunch of people. 

And another BIG THANKS to our dear member Steve Yeoman (who often joins our zoom calls) for convincing a friend. Steve used to run but was told to stop by his doctor as too much hard impact on knees.

Have a look at the highlights of the great event!

[envira-gallery id="32155"]

You can make a GREAT difference to MDS patients TODAY

Every donation, big or small, helps us maintain our

FREE services to MDS patients!

WITH YOUR HELP, WE CAN HELP


Meet our hero Nick, riding from the far south of Cornwall to the Scottish Highlands

From Land's End to John O'Groats for MDS UK

MDS Patient Support
On the 30th July Nick Harpur set off from Land’s End in the direction of John O’Groats.
He was planning to follow the GB Divide route, a 2000km (600km off-road) route that snakes its way up through England, Wales and Scotland via small lanes, drove roads and spectacular mountain passes, with 27,000 metres of climbing.
He would sleep in a bivvy bag (basically a sack) in bothies (basically a shack) and in the gardens of kind strangers he contacted via the Warmshowers cycle touring website, expecting to average approximately 12 hours in the saddle every day.

Joan's story

Nick wrote in his JustGiving page:

In January last year I learnt that Lydia’s mum, Joan, was diagnosed with the condition Myelodysplastic Syndrome (a rare blood cancer). As you can imagine, it has been a difficult 18 months for Joan and all of the family, and, whilst I can’t do anything to change Joan’s condition I’d like to seize the opportunity to raise some money and awareness for an organisation that can. 

MDS UK have been a massive support to Joan and the family throughout this really difficult period. I hope you can join me in attempting to repay just some of the kindness and love this inspiring and brave woman shows so many by supporting MDS UK.

Any donation you can give will make a difference to the impact that MDS can have and will be greatly appreciated.

Day 1: Nick at Lands End

MDS Patient Support

His first day on the bike

MDS Patient Support

Day 2: 153.64 km

Second day of Nick’s journey. As he crosses Cornwall he writes:

Shortest of the full days I have planned but it was brilliant. “Camel trail” a particular highlight, that and the pasty I had in Torrington. Need to prep myself for a 220km all the way to Chepstow tomorrow ?

Nick spent 6 months planning and training for this ride to ensure his route, equipment and body were in the best place they could be. Still, he knows there will be unexpected challenges along the way.

MDS Patient Support

MDS Patient Support

Day 3: 177.31 km – An eventful day

The biggest highs and lows of the trip so far, both literally and metaphorically. It started with an endless 25% climb up to the Old Brynmawr Ironworks, then a very enjoyable gravel climb up to an old quarry with terrifying views of “The Gap”.
It was every bit as hard as I feared, but so rewarding and beautiful, then I was hit by a big storm, dried off by climbing the Sennybridge military road before heading into the wilderness to find my bothy which involved an hour hiking through bracken (first big routing error!), 5 river crossings, and the most incredible road of the trip (and possibly my life) before finally being greeted by Moel Pyrsgau bothy in the woods.
Not a day I’ll forget in a hurry

MDS Patient Support

MDS Patient Support

Every day we post a new leg of Nick’s monumental journey in support of MDS UK. Come back tomorrow for an update!

A BIG THANK YOU to Nick for putting in such an incredible effort in aid of our small charity. We thank him not only for the fundraising, but also for the fabulous awareness of MDS he is generating.

Today, more than ever – due to Covid – we need generous people like Nick to help us assist MDS patients and their families.


Blood cancer: supporting mind and body

MDS Patient Support

Surabhi Chaturvedi, Psychotherapist at King’s College Hospital NHS Foundation Trust’s Haematology Department, blogs about the emotional impact of being diagnosed with a blood cancer and the importance of supporting people’s mental wellbeing throughout the course of their illness.

Although all serious health conditions have a psychological impact, blood cancers present some specific challenges. Some of the treatments (such as Bone Marrow Transplants) are intensive and involve repeated hospital admissions and physical isolation due to risks of infection. Disruptions to life in the form of fatigue or graft versus host disease (GvHD, a condition where the donated bone marrow mistakes the person’s body as ‘foreign’ and attacks the host’s cells) can continue after treatment comes to an end. Lack of awareness can occasionally translate into a lack of understanding from caregivers or colleagues.

Helping patients cope emotionally

There is no fixed ‘template’ for coping with blood cancer that can be applied to all patients. Each individual’s response is a complex interplay of factors related to their illness (prognosis and treatment options) and personal/social factors (levels of practical and social support, previous experience of stressors, personality traits, and their existential or spiritual beliefs i.e. their thoughts about the meaning of life). Similarly, patient support needs don’t follow a specific timeline. Some people need support during the initial stages following diagnosis and others require support after the end of treatment.

Among a variety of emotions, a sense of loss can pervade the patient’s experience.

Although none of us has any guarantees about our futures, our natural human tendency is to have aspirations and make plans for the future. To an extent this sense of safety is necessary to participate in life and it can feel out-of-reach to someone diagnosed with a serious illness. With time, there may be a shift in this feeling but it is important to understand that this loss is felt very acutely by many people.

Patients often describe their journey as an ‘emotional rollercoaster’.

This metaphor feels accurate to describe the multiple physical and emotional adjustments patients (and carers) have to make. At the same time as processing thoughts and feelings associated with the diagnosis, patients have to face the practicalities of illness, including further investigations or treatment. The changes caused by side effects of treatment often have a profound effect on people’s sense of self or identity, and the personal and professional roles in which they have always viewed themselves.

Keeping friends and family informed can also be emotionally demanding.

Amidst all this, the picture of coping with a blood cancer can also include more positive emotions such as hope, or of gratitude towards loved ones and professionals.

Mark, a male patient in his 40s, was diagnosed with a blood cancer requiring a ‘watch-and-wait’ approach. His disease was not severe enough to require treatment, but his life was suddenly thrown into the shadow cast by the threat of cancer. Mark had suffered from anxiety in the past and the diagnosis re-triggered this. He found himself sleepless and preoccupied by thoughts about his deterioration and his death. Similar to other patients in his circumstances, this was mixed with feelings of confusion about ‘how to feel’. Therapy was helpful not only to treat Mark’s anxiety through coping strategies to regulate his emotions and de-escalate catastrophic negative thoughts, but also to learn to live with uncertainty. A year later, Mark's blood cancer did progress and had to undergo a stem cell transplant. He sought psychological support once more to cope with his six-week hospital admission when he suffered multiple physical symptoms. For now, Mark remains well and disease-free.

Distinguishing emotional distress from mental illness

Like any of us, people diagnosed with blood cancers can suffer from mental health issues such as depression or anxiety. However, viewing the process of adjustment through the lens of a mental illness isn’t always helpful because it can lead us to pathologise (treating something as psychologically abnormal) normal and valid emotional states. In a cancer setting, patients (and carers) can experience complex and extreme distress that doesn’t always coincide with diagnostic criteria for mental illness.

Moreover, people can appear ‘fine’ on the outside, but still benefit from therapy in order to process their experience of cancer and overcome significant barriers to psychological wellbeing. It is important to distinguish emotional distress from mental illness, and to offer support for both.

At the heart of psychological therapy is the ‘therapeutic relationship’ – a relationship based on trust, safety, respect, empathy and compassion. Research has shown that this relationship is just as important as the specific techniques or methods used by a therapist.

 

The role of psychotherapy in a cancer setting

Patients often wish to protect loved ones from pain and discomfort, and vice versa. Counselling and psychotherapy offer people a safe space in which to vent difficult emotions, speak openly about fears and worries or talk about the impact of side effects without worrying that they will upset someone or be judged.

A psychological therapist’s role in cancer settings is varied. It includes journeying alongside patients as they navigate the highs and the lows, and bearing witness to inevitable aspects of illness and treatment. We help patients identify specific psychological traits (thoughts or behaviours) that have unhelpful consequences (e.g. increased distress) but can be changed through insight and coping strategies. We support patients to retain or regain a sense of agency amidst helplessness and vulnerability. We are also trained to assess and help patients overcome depression, anxiety, post-traumatic stress or other mental health issues in addition to coping with cancer.

More Information



COVID vaccine efficacy and MDS: In conversation with Dr Austin Kulasekararaj

Watch the video of MDS UK Zoom Cafe on the 19th July 2021

On the 19th of July we had an informative conversation with Dr Austin Kulasekararaj, Consultant Haematologist, King's College Hospital, London, on issues and concerns around COVID-19 "Freedom Day" and the efficacy of the Covid vaccine for MDS patients.
Watch the video and read the excerpts below.

"Patients with their immune system compromised have to be still extremely careful"

"Obviously today is a big day, it's called Freedom Day, but I think for MDS patients - and generally for the community of blood cancers or any other conditions with patients with their immune system compromised - we have to be still extremely careful.

It's great that quite a lot, if not most of the people on this call would have had both the vaccines. They will provide a degree of protection against getting severe COVID.

There is (still) a possibility of getting COVID, but the complications of getting severe infection, hospitalization and complications are going to be significantly reduced.

What we're all debating about is the degree of protection. I think that is the major question."

Dr Austin Kulasekararaj

Dr Austin Kulasekararaj

"We've screened around 40 patients after receiving the 2nd vaccination to see their protective ability.

In a couple of months we'll have some scientific data to see when is the right time to boost the vaccination and how long-lasting the immune response will be."

 

"We are now getting the data to understand how cancer patients' immune system responds to vaccination"

"Thanks to a number of people on this call we've been able to do a test,  the SOAP study, and test for your antibody levels and also other aspects of the immune system two weeks to four weeks after you've received the second jab.

We've screened around 40 patients at a specific time point after receiving the second vaccination to see their protective ability. You would have noticed that I did not use the word antibody, because antibodies are only one aspect of the immune system which is measured to look at the response to vaccination. But there are so many other aspects of the immune system which we are able to measure, including what is called the t-cells, which are another bit of the immune system which will look at the protective response against COVID.

The study is very interesting because that's sort of going to be the real world (question) going forward: you would have had two vaccines, you would have possibly had a booster, what is the chance that you could get severe COVID or get complications due to COVID? That is something which the SOAP study is particularly looking to understand.

In a couple of months things will be a bit clearer, prior to the planned roll out for an autumn booster or early winter booster of the vaccination, so we'll be able to have some data, some scientific data, to guide us, to see when is the right time to boost the vaccination and also to see how long-lasting the immune response will be."

MDS Zoom Café

MDS Zoom Café

"I'd say, if there is a halfway house between totally locking yourself in a room, being totally vigilant and not interacting, versus going all out and without a mask, if there is a halfway house somewhere, that's where we should all as MDS patients fit in."

Learn more about Covid vaccine efficacy and blood cancer

Visit bloodcancer.org.uk and learn what we know so far about covid vaccine effectiveness in people with different types of blood cancer. The page is updated regularly.

https://bloodcancer.org.uk/support-for-you/coronavirus-covid-19/covid-vaccine-blood-cancer/covid-vaccine-efficacy-blood-cancer/


Important News for MDS Patients: Government Update for the Extremely Vulnerable 21/07/2021

Following the announcement of the lifting in England of all COVID-19 restrictions from July 19th, the Government has issued new Guidance for people classed as Clinically Extremely Vulnerable (CEV), including all MDS patients.

The full Guidance can be found here:

Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19

We continue to advise MDS patients to to remain very cautious, until further specific advice from MDS experts (who we are currently consulting).

SO, at the very least:

  • continue to wear a mask
  • continue to socially distance
  • continue frequent hand washing

More lobbying is underway via the Blood Cancer Alliance (of which MDS UK is a member) to raise awareness of the situation for blood cancer patients. The following letter was recently sent to the Prime Minister, with a copy to the Secretary of State for Health and Social Care.

We would ask you to please forward this letter to your MP, with a statement about how this impacts YOU personally, as a person living with MDS:

Letter to the Prime Minister from the Blood Cancer Alliance

The full text of the revised Government Guidance:

Who this guidance is for

This guidance is for everyone in England who has been identified as clinically extremely vulnerable from coronavirus (COVID-19). This includes those people who have been identified by the NHS as being clinically extremely vulnerable and those identified through the COVID-19 population risk assessment. All of those identified have been added to the Shielded Patient List, and more information on the criteria used is available below. If you have been identified as being clinically extremely vulnerable, you will previously have received a letter from the NHS or from your GP telling you this. You may also have been advised to shield in the past.

There is different guidance for clinically extremely vulnerable people living in Scotland, living in Wales and living in Northern Ireland.

What has changed

Shielding advice was paused on 1 April 2021. If you require additional care and support to help you stay safe and well, there is further advice below.

As restrictions have been eased following the move to Step 4 of the roadmap, we are advising clinically extremely vulnerable people, as a minimum, to follow the same guidance as everyone else. It is important that everyone adheres to this guidance.

However, as someone who is at a higher risk of becoming seriously ill if you were to catch COVID-19, you may wish to think particularly carefully about additional precautions you might wish to continue to take. Individuals may choose to limit the close contact they have with those they do not usually meet with in order to reduce the risk of catching or spreading COVID-19, particularly if they are clinically extremely vulnerable and if COVID-19 disease levels in the general community are high. It is important to respect and be considerate of those who may wish to take a more cautious approach as restrictions are lifted.

We understand you may have concerns and wish to know how you can continue to take precautions to keep yourself safe. There are things that you can continue to do to lower your risk of infection and prevent the spread of COVID-19, and some examples are outlined in the sections below.

Although the vast majority of the population, including the clinically extremely vulnerable, will be well protected by the vaccine, no vaccine is 100% effective and there is emerging evidence that suggests that some immunocompromised and immunosuppressed individuals may not respond as well to COVID-19 vaccines as others. However, all COVID-19 vaccines should offer some degree of protection. Therefore, it is really important that you have both your first and second dose of the coronavirus vaccine.

A recent study from Public Health England (PHE), which looked at more than 1 million people in at-risk groups, found that people who are immunosuppressed are significantly better protected from symptomatic infection following the second dose of a COVID-19 vaccine.

We are continuing to work to better understand who is less well protected by the COVID-19 vaccines, and there are various studies underway that are looking at this.

If you have any questions or concerns about what it means to be clinically extremely vulnerable and how COVID-19 may impact your health condition, have a look at the NHS website.

If you are concerned about your general physical and mental wellbeing or if you are immunocompromised or immunosuppressed and have any concerns about what this means for you, then please contact your GP practice or specialist who can provide you with support and guidance on any further measures you can take to further reduce your risk of infection.

Vaccination

Everyone on the Shielded Patient List should already have been offered a COVID-19 vaccine. If you have not yet received your first dose, please contact your GP, book your vaccination appointment online or call 119. If you have received your first dose, you should still ensure you take up your second dose of the vaccine. Having 2 doses should further increase your level of protection. For some with immunosuppression it may only be with your second dose that a significant immune response is triggered.

The Joint Committee on Vaccination and Immunisation (JCVI) interim advice, based on existing evidence, is to offer COVID-19 booster vaccines to the most vulnerable, starting from September 2021. The booster programme will aim to provide additional resilience against variants, and maximise protection in those who are the most vulnerable to serious disease from COVID-19 ahead of the winter months, when there is increased pressure on the NHS as non-COVID-19 emergency demand is at its highest.

A booster dose would be offered to groups in 2 stages and, if possible, delivered alongside the annual influenza vaccination. In the first stage, a booster would be offered to:

  • adults aged 16 years and over who are immunosuppressed
  • those living in residential care homes for older adults
  • all adults aged 70 years or over
  • adults aged 16 years and over who are considered clinically extremely vulnerable
  • frontline health and social care workers

As soon as practicable after the first stage, the second stage would see a booster offered to:

  • all adults aged 50 years and over
  • adults aged 16 to 49 years who are in an influenza or COVID-19 at-risk group
  • adult household contacts of immunosuppressed individuals

Further details of any booster campaign, including when, for whom and which vaccine(s) would be used, will become available once the JCVI has considered further evidence and made its final recommendations.

Children under 16 years of age, even if they are clinically extremely vulnerable, are at low risk of serious illness and death from COVID-19 and are not routinely recommended for vaccination. However, the JCVI has advised that the following groups of children should be offered vaccination against COVID-19:

  • 12 to 15 year olds with the following health conditions:
    • severe neuro-disabilities
    • Down’s syndrome
    • underlying conditions resulting in immunosuppression
    • those with profound and multiple learning disabilities, severe learning disabilities or who are on the learning disability register
  • 12 to 17 year olds who are healthy, but who live with individuals (adults or children) who are immunosuppressed

All 16 and 17 year olds who are either clinically extremely vulnerable or have underlying health conditions were included in Phase One of the vaccine deployment programme, and should therefore already have been offered a COVID-19 vaccine.

The NHS will contact eligible children to invite them for vaccination. If a parent or guardian thinks that their child is eligible but has not been contacted by the end of August, they should contact their GP.

No vaccine is 100% effective and therefore even if you have had both doses, there is still no absolute guarantee that you will not become ill from COVID-19. As such, you should continue to follow the guidance that is in place for everyone.

Socialising inside and outside the home

We recognise that restrictions on socialising with friends and family have been difficult for everyone, especially for clinically extremely vulnerable people during periods of shielding. Guidance on socialising inside and outside of the home with your friends and family has been updated for everyone. From 19 July, there are no longer any limits on the number of people or households that you can meet with. In addition, the requirement to socially distance from others has ended, other than in a few exceptions.

Social distancing rules (2 metres or 1 metre with additional mitigations) have been lifted. You should continue to consider the risks of close contact with others, particularly if you are clinically extremely vulnerable or not yet fully vaccinated. The risk of catching or passing on COVID-19 is generally higher:

  • in crowded spaces, where there are more people who might be infectious
  • in enclosed indoor spaces where there is limited fresh air
  • when COVID-19 disease levels are high in the general community

Everyone will only be required to socially distance in limited circumstances, such as maintaining infection control in health and care settings.

As someone identified as clinically extremely vulnerable, we acknowledge that social distancing has been particularly difficult for you, especially during periods of shielding. Because clinically extremely vulnerable people are at higher risk of severe illness from COVID-19, you may wish to think particularly carefully about taking precautions when meeting others you do not usually meet with in order to reduce the risk of catching or spreading COVID-19. For example, you could:

  • meet outside if possible – the particles containing the virus that causes COVID-19 are quickly blown away which makes it less likely that they will be breathed in by another person
  • make sure the space is well ventilated if you meet inside; open windows and doors or take other action to let in plenty of fresh air – please see the COVID-19: ventilation of indoor spaces guidance for more information
  • consider whether you and those you are meeting have been vaccinated – you might want to wait until 14 days after everyone’s second dose of a COVID-19 vaccine before being in close contact with others
  • wash your hands regularly and avoid touching your face
  • consider continuing to practice social distancing if that feels right for you and your friends
  • asking friends and family to take a lateral flow test before visiting you
  • ask home visitors to wear face coverings

You are encouraged to go outside for exercise and can do so freely now. You can find tips and advice on staying active and eating healthily at NHS Better Health. You can find more information online about how to stop the spread of coronavirus.

Work

From 19 July, social distancing measures have ended in the workplace and it is no longer necessary for the government to instruct people to work from home.

However, employers still have a legal responsibility to protect their employees and others from risks to their health and safety. Your employer should be able to explain to you the measures they have in place to keep you safe at work. Some employers may request employees to undertake regular testing for COVID-19 to identify people who are asymptomatic.

The Health and Safety Executive (HSE) has published guidance on protecting vulnerable workers, including advice for employers and employees on how to talk about reducing risks in the workplace.

If you need support to work at home or in the workplace you can apply for Access to Work. Access to Work may provide support for the disability-related extra costs of working that are beyond standard reasonable adjustments an employer must provide. Access to Work will prioritise applications from disabled people who are in the clinically extremely vulnerable group.

If you have access to occupational health and employee assistance programmes in the workplace, these services can also provide you with a range of health support and advice for your physical and mental health needs.

The Coronavirus Job Retention Scheme (furlough) is available until 30 September. You may be eligible throughout this period, even when shielding is paused, providing your employer agrees. The Self-Employment Income Support Scheme (SEISS) is also available until 30 September.

You may be eligible for Statutory Sick Pay (SSP) or Employment and Support Allowance (ESA) if you are sick or incapable of work, either due to coronavirus or other health reasons, subject to meeting the eligibility conditions.

If you have concerns about your health and safety at work then you can raise them with your workplace union, HSE or your local authority. Where employers are not managing the risk of COVID-19, HSE and local authorities will take action which can range from the provision of specific advice, issuing enforcement notices, stopping certain work practices until they are made safe and, where businesses fail to comply with enforcement notices, this could lead to prosecution.

The existing employment rights framework provides protections against discrimination, unfair dismissal and detriment. Specific guidance has been published for employers and workers on work absences due to coronavirus (COVID-19).

Citizens Advice also has information about your rights at work and how to solve problems in the workplace. If you have concerns you can also get advice on your specific situation and your employment rights by visiting the Acas website or calling the Acas helpline on 0300 123 1100.

School, college and other educational settings

It is important that children attend school for their education, wellbeing, mental health and long-term development. Clinically extremely vulnerable pupils and students should have returned to their school or other educational setting. This includes early years provision, wraparound childcare and applicable out-of-school settings.

Where parents are concerned about their child’s attendance, they should speak to their child’s educational setting about their concerns and discuss the measures that have been put in place to reduce the risk. They should also discuss other measures that can be put in place to ensure their children can regularly attend.

The use of rapid lateral flow tests helps us to identify individuals with COVID-19 who do not have symptoms, which make up around a third of all cases. Finding asymptomatic cases, along with other infection prevention and control measures can help us manage the spread of the virus.

To safeguard the health of the teaching workforce and keep as many staff, pupils and students in school and college as possible, we have made rapid lateral flow tests available to schools and colleges. Lateral flow tests can also be accessed directly for households of primary and secondary school pupils and for households of primary and secondary school staff. This testing will also help keep safe those in the community who are clinically extremely vulnerable and their families.

All early years providers, schools and colleges are continuing to put in place measures to help minimise the risk of spreading COVID-19. These include handwashing, use of face coverings in specific situations, enhancing cleaning, ventilation and managing suspected and confirmed cases.

Travel

Whilst the legal requirement to wear a face covering has been lifted from 19 July, the government expects and recommends that people continue to wear face coverings in crowded areas, such as public transport. Wearing a face covering, especially when there is close contact between people in enclosed and crowded spaces will still help to reduce the risk of spreading COVID-19. It may also help those who are clinically extremely vulnerable feel more relaxed. It is important that face coverings fit securely around the face and safely cover the mouth and the nose.

ar sharing with people from outside your household or support bubble, and ensure that you use a face covering when using taxis.

Going to shops and pharmacies

Clinically extremely vulnerable people are now advised to follow the guidance that applies to the rest of the population. You may still wish to consider going to the shops and pharmacy at quieter times of the day.

Priority access to supermarket delivery slots using the shielding support website ended on 21 June. After 21 June, you can continue to book delivery slots in the usual manner from a supermarket.

You can continue to ask for short-term help from the NHS Volunteer Responder scheme with telephone support if you are feeling lonely, or for help with collecting shopping (if you are unable to use any of the online or telephone shopping options now available through most supermarkets), medication or other essential supplies that you need delivered to your home. You can ask for help by visiting NHS Volunteer Responders or calling 08081963646 between 8am and 8pm.

If you require additional care and support

It is important that you continue to receive the care and support you need to help you stay safe and well. Providers of social care and medical services are making every effort to ensure services remain open and as safe as possible.

You should continue to seek support from the NHS for your existing health conditions. You can access a range of NHS services from home, including ordering repeat prescriptions or contacting your health professional through an online consultation. To find out more visit NHS Health at home, or download the NHS App. If you have an urgent medical need, call NHS 111 or, for a medical emergency, dial 999.

The measures you may have taken to respond to COVID-19 may have triggered feelings of worry, distress or loneliness. These feelings are a completely normal response to an unprecedented period of disruption. As restrictions ease and the economy is gradually and safely reopened, you may find that your wellbeing improves as you reconnect with family and friends, and return to routines and activities that help to keep you well.

You can visit the Every Mind Matters website for advice and practical steps that you can take to support your wellbeing and manage your mental health. If you are feeling lonely, the Let’s Talk Loneliness website also has a variety of tips, advice and further resources that you may find helpful. The NHS Volunteer Responders programme also offers telephone support through Check in and Chat Volunteers. Check In and Chat Plus Volunteers provide a regular check-in by telephone to you for up to 10 weeks, with typically 3 calls taking place each week.

If you are struggling with your mental health, you can reach out for support. Visit the Hub of Hope to find local sources of mental health support and services, both from the NHS and from other organisations close to you. Your GP will be able to refer you to NHS talking therapies, which can provide treatment for depression, anxiety or post-traumatic stress disorder, or you can self-refer online.

If you or a loved one are experiencing a mental health crisis, you can call a local NHS mental health helpline for 24-hour advice and support, or contact the Samaritans on 116 123 or through emailing jo@samaritans.org

Any carers or visitors who support you with your everyday needs can continue to visit. They should continue to follow the guidance on how to stop the spread of COVID-19 at all times.

You can also access additional support from your energy supplier. Energy suppliers are required by the regulator, Ofgem, to hold a register of customers in a vulnerable circumstance, called a Priority Service Register. If you are clinically extremely vulnerable you can be added to this register. For information about how to be added to the register and the additional services your supplier can provide you, please visit Ofgem’s website.

Telecom providers are also required by their regulator, Ofcom, to support their vulnerable customers. For information about the additional services your supplier may be able to provide you as a vulnerable customer, please visit Ofcom’s website.

If you are struggling as a result of coronavirus, find out how to get coronavirus support or contact your local council to find out what support is available.

Definition of clinically extremely vulnerable groups

People who are defined as clinically extremely vulnerable are thought to be at very high risk of serious illness from coronavirus. There are 3 ways you may be identified as clinically extremely vulnerable and therefore included on the Shielded Patient List:

  1. You have one or more of the conditions listed below.
  2. Your clinician or GP has added you to the Shielded Patient List because, based on their clinical judgement, they deem you to be at high risk of serious illness if you catch the virus.
  3. You have been identified through the COVID-19 population risk assessment as potentially being at high risk of serious illness if you catch the virus.

If you do not fall into any of these categories, and have not been contacted to inform you that you are on the Shielded Patient List, you should continue to follow the guidance that applies to everyone.

If you think there are good clinical reasons why you should be considered clinically extremely vulnerable, discuss your concerns with your GP or hospital clinician. People with the following conditions are automatically deemed clinically extremely vulnerable and therefore have been previously included on the Shielded Patient List:

  • solid organ transplant recipients
  • people with specific cancers:
    • people with cancer who are undergoing active chemotherapy
    • people with lung cancer who are undergoing radical radiotherapy
    • people with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
    • people having immunotherapy or other continuing antibody treatments for cancer
    • people having other targeted cancer treatments that can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
    • people who have had bone marrow or stem cell transplants in the last 6 months or who are still taking immunosuppression drugs
  • people with severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary disease (COPD)
  • people with rare diseases that significantly increase the risk of infections (such as severe combined immunodeficiency (SCID), homozygous sickle cell disease)
  • people on immunosuppression therapies sufficient to significantly increase risk of infection
  • problems with your spleen, for example splenectomy (having your spleen removed)
  • adults with Down’s syndrome
  • adults on dialysis or with chronic kidney disease (stage 5)
  • women who are pregnant with significant heart disease, congenital or acquired
  • other people who have also been classed as clinically extremely vulnerable, based on clinical judgement and an assessment of their needs – GPs and hospital clinicians have been provided with guidance to support these decisions

Keep checking our website for news, and make sure you are registered as a member, and receiving our emails.

Any specific issues – please contact us, so we can report the problem to NHS England directly: info@mdspatientsupport.org.uk, or call 0207 733 7558.

MDS UK team

Please help us support more patients!

Donate on MDS UK Virgin Money Giving Page


Guidelines for the management of adult patients with myelodysplastic syndromes

The British Society of Haematology has now issued their 2021 updated Guidelines for Myelodysplastic Syndromes (MDS).

These guidelines are written by experts in MDS and destined to be used by all UK haematologists to assist in the optimal care and treatment of their MDS patients.

These are guidelines, not rules, and the clinicians will adapt these to care for individual patients, depending on their exact sub-type, co-morbidities, circumstances and patient wishes.

Patients and families can of course read these guidelines, but remember these are not written for an audience of patients.

As patients or carers, we recommend you read our Patient Handbook, or browse articles and videos on our website, which are less technical. We will be reflecting these updates in our next edition of the patient handbook, due out in October 2021.

You can listen to the very good podcast by Dr Sally Killick, which is fairly accessible, despite also been aimed at a clinical audience.

Listen in particular to the beginning of the podcast, which clearly states that MDS patients should be seen by a haematologist specialising in MDS, and that every case should be discussed in an MDT (Multi-disciplinary Team meeting).


He shoots, he scores! He saves a life! Hero England fan!

This story is now making headlines, thanks to the selfless and generous attitude of Sam Astley, who opted to donate his stem cells instead of attending the England football match!

Sam decided to register as a stem cell donor, thank to our long term MDS UK Patient Support Group member Simon Wilkes, who was diagnosed with the rare blood cancer Myelodysplastic Syndromes several years ago.

MDS Patient Support
MDS Patient Support

After contacting MDS UK, Simon decided to fundraise for us, as well as Anthony Nolan, saving the lives of people with blood cancer, to raise awareness of his blood cancer, and the need for more stem cell donors.

Simon organised several recruitment drives over the years, registering numerous donors, including Sam Astley.
Simon's life was very sadly turned upside down, following the death of his son. Simon and his family heve been holding events in his memory, supporting both MDS UK and Anthony Nolan.

We have since heard that Sam was given tickets by EUFA2020 to watch the final! England football team Huge thank you on behalf of the blood cancer community!

And thanks to Simon for all his support.
https://www.bbc.co.uk/news

 

More on Sam Astley who donated his stem cells on the night of the England football match and Simon Wilkes, who has MDS, and organised a recruitment drive to support MDS UK Patient Support Group and Anthony Nolan, saving the lives of people with blood cancer. So grateful to both for the absolutely amazing support, generosity and selflessness.

Thank you to all the papers and media The Independent BBC News London Evening Standard Daily Mail Good Morning Britain for running this amazing story.

And vivo, vivo sponsors for coming up with tickets to the final!

Gary Lineker thanks for all the support!

Please give this amazing couple a huge welcome England football team. He is saving lives for blood cancer.

And renewed thanks to Simon Wilkes who has the rare blood cancer MDS Myelodysplastic Syndromes and initiated the recruitment drive!

'Read more about the fabulous support from Simon Wilkes to MDS UK. Linking his love for football, especially Stourbridge FC, and the need to support smaller charities like MDS UK.

As well as raise awareness for stem cell donations with our brilliant colleagues from Anthony Nolan.'

More on Sam Astley who donated his stem cells on the night of the England football match and Simon Wilkes, who has MDS, and organised a recruitment drive to support MDS UK Patient Support Group and Anthony Nolan, saving the lives of people with blood cancer. So grateful to both for the absolutely amazing support, generosity and selflessness.

Thank you to all the papers and media The Independent BBC News London Evening Standard Daily Mail Good Morning Britain for running this amazing story.

And vivo, vivo sponsors for coming up with tickets to the final!

Gary Lineker thanks for all the support!

Please give this amazing couple a huge welcome England football team. He is saving lives for blood cancer.

And renewed thanks to Simon Wilkes who has the rare blood cancer MDS Myelodysplastic Syndromes and initiated the recruitment drive!

'Read more about the fabulous support from Simon Wilkes to MDS UK. Linking his love for football, especially Stourbridge FC, and the need to support smaller charities like MDS UK.

As well as raise awareness for stem cell donations with our brilliant colleagues from Anthony Nolan.'

MDS Patient Support
MDS Patient Support

Simon (who had MDS), wife Lynn, and sons Ben – as well as Olly (who very sadly took his own life a few years ago).

The family has been supporting and fundraising for MDS UK and Anthony Nolan for years.


Silence Therapeutics

The pharma company Silence Therapeutics organised an international event in June with their employees, their #MonthToMove, challenging the Silence team to get ‘moving’ for their partner patient groups, with a pound donated by Silence for every kilometre covered.

MDS Patient Support

The team collectively covered 8,558km, meaning Silence will donate £8,558 spread across their seven core charity partners. They also raised a further £650 via their JustGiving page, bringing the current total to £9,208. This means they will be donating £1,315 to MDS UK.

We are super impressed and very grateful to all employees for rising so energetically to the challenge, and to Silence Therapeutics for the ongoing support and commitment to patient charities.

MDS Patient Support

Silence Therapeutic aims at transforming the treatment of diseases through precision engineered medicines. Silence is advancing a new generation of medicines to potentially address the needs of patients who have limited or inadequate treatment options, MDS patients among them.

All the money raised will go to ensure that all patients and families receive the attention and information they need during those particularly difficult times – straight after diagnosis, at treatment changes, time of transplant or progression of the condition.


Free donations by shopping